nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2D6—Vinorelbine—ovarian cancer	0.0761	0.182	CbGbCtD
Methimazole—CYP3A4—Topotecan—ovarian cancer	0.0686	0.165	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—ovarian cancer	0.0596	0.143	CbGbCtD
Methimazole—CYP2C9—Paclitaxel—ovarian cancer	0.0584	0.14	CbGbCtD
Methimazole—CYP3A4—Vinorelbine—ovarian cancer	0.0484	0.116	CbGbCtD
Methimazole—CYP3A4—Paclitaxel—ovarian cancer	0.034	0.0815	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—ovarian cancer	0.0288	0.0691	CbGbCtD
Methimazole—CYP3A4—Docetaxel—ovarian cancer	0.0246	0.0589	CbGbCtD
Methimazole—Drug fever—Chlorambucil—ovarian cancer	0.0204	0.059	CcSEcCtD
Methimazole—CYP3A4—Doxorubicin—ovarian cancer	0.0183	0.0439	CbGbCtD
Methimazole—Neuropathy peripheral—Altretamine—ovarian cancer	0.0105	0.0304	CcSEcCtD
Methimazole—Pigmentation disorder—Paclitaxel—ovarian cancer	0.0104	0.0302	CcSEcCtD
Methimazole—Neuritis—Chlorambucil—ovarian cancer	0.0091	0.0264	CcSEcCtD
Methimazole—Drug fever—Docetaxel—ovarian cancer	0.00884	0.0256	CcSEcCtD
Methimazole—Vertigo—Altretamine—ovarian cancer	0.00751	0.0217	CcSEcCtD
Methimazole—Leukopenia—Altretamine—ovarian cancer	0.00748	0.0217	CcSEcCtD
Methimazole—Thrombocytopenia—Altretamine—ovarian cancer	0.00668	0.0193	CcSEcCtD
Methimazole—Pigmentation disorder—Epirubicin—ovarian cancer	0.00596	0.0173	CcSEcCtD
Methimazole—Lymphadenopathy—Chlorambucil—ovarian cancer	0.00578	0.0167	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—ovarian cancer	0.00552	0.016	CcSEcCtD
Methimazole—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00486	0.0141	CcSEcCtD
Methimazole—Neuritis—Paclitaxel—ovarian cancer	0.00466	0.0135	CcSEcCtD
Methimazole—Vomiting—Altretamine—ovarian cancer	0.00434	0.0126	CcSEcCtD
Methimazole—Nausea—Altretamine—ovarian cancer	0.00405	0.0117	CcSEcCtD
Methimazole—Neuritis—Docetaxel—ovarian cancer	0.00395	0.0114	CcSEcCtD
Methimazole—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00373	0.0108	CcSEcCtD
Methimazole—Body temperature increased—Carboplatin—ovarian cancer	0.00373	0.0108	CcSEcCtD
Methimazole—Jaundice—Chlorambucil—ovarian cancer	0.00371	0.0107	CcSEcCtD
Methimazole—Ageusia—Docetaxel—ovarian cancer	0.00364	0.0105	CcSEcCtD
Methimazole—Neuropathy peripheral—Topotecan—ovarian cancer	0.00332	0.00961	CcSEcCtD
Methimazole—Neuropathy peripheral—Melphalan—ovarian cancer	0.00325	0.00941	CcSEcCtD
Methimazole—Jaundice—Melphalan—ovarian cancer	0.00323	0.00935	CcSEcCtD
Methimazole—Alopecia—Chlorambucil—ovarian cancer	0.00302	0.00873	CcSEcCtD
Methimazole—Hepatitis—Melphalan—ovarian cancer	0.00298	0.00861	CcSEcCtD
Methimazole—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00284	0.00822	CcSEcCtD
Methimazole—Agranulocytosis—Vinorelbine—ovarian cancer	0.0027	0.00782	CcSEcCtD
Methimazole—Alopecia—Topotecan—ovarian cancer	0.00268	0.00777	CcSEcCtD
Methimazole—Neuritis—Epirubicin—ovarian cancer	0.00267	0.00772	CcSEcCtD
Methimazole—Leukopenia—Chlorambucil—ovarian cancer	0.00266	0.0077	CcSEcCtD
Methimazole—Alopecia—Melphalan—ovarian cancer	0.00263	0.00761	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—ovarian cancer	0.00247	0.00714	CcSEcCtD
Methimazole—Ageusia—Epirubicin—ovarian cancer	0.00246	0.00711	CcSEcCtD
Methimazole—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00237	0.00687	CcSEcCtD
Methimazole—Leukopenia—Topotecan—ovarian cancer	0.00237	0.00686	CcSEcCtD
Methimazole—Leukopenia—Melphalan—ovarian cancer	0.00232	0.00671	CcSEcCtD
Methimazole—Alopecia—Vinorelbine—ovarian cancer	0.0023	0.00665	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—ovarian cancer	0.00227	0.00658	CcSEcCtD
Methimazole—Myalgia—Topotecan—ovarian cancer	0.00225	0.00652	CcSEcCtD
Methimazole—Arthralgia—Topotecan—ovarian cancer	0.00225	0.00652	CcSEcCtD
Methimazole—Myalgia—Melphalan—ovarian cancer	0.0022	0.00638	CcSEcCtD
Methimazole—Dyspepsia—Chlorambucil—ovarian cancer	0.00213	0.00618	CcSEcCtD
Methimazole—Oedema—Melphalan—ovarian cancer	0.00211	0.00612	CcSEcCtD
Methimazole—Thrombocytopenia—Topotecan—ovarian cancer	0.00211	0.00612	CcSEcCtD
Methimazole—Thrombocytopenia—Melphalan—ovarian cancer	0.00207	0.00599	CcSEcCtD
Methimazole—Vertigo—Vinorelbine—ovarian cancer	0.00203	0.00589	CcSEcCtD
Methimazole—Leukopenia—Vinorelbine—ovarian cancer	0.00203	0.00586	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00197	0.00569	CcSEcCtD
Methimazole—Paraesthesia—Topotecan—ovarian cancer	0.00194	0.00561	CcSEcCtD
Methimazole—Urticaria—Chlorambucil—ovarian cancer	0.00193	0.00558	CcSEcCtD
Methimazole—Arthralgia—Vinorelbine—ovarian cancer	0.00193	0.00558	CcSEcCtD
Methimazole—Myalgia—Vinorelbine—ovarian cancer	0.00193	0.00558	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00193	0.00558	CcSEcCtD
Methimazole—Body temperature increased—Chlorambucil—ovarian cancer	0.00192	0.00555	CcSEcCtD
Methimazole—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00191	0.00553	CcSEcCtD
Methimazole—Dyspepsia—Topotecan—ovarian cancer	0.0019	0.0055	CcSEcCtD
Methimazole—Paraesthesia—Melphalan—ovarian cancer	0.0019	0.0055	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—ovarian cancer	0.00187	0.00541	CcSEcCtD
Methimazole—Dyspepsia—Melphalan—ovarian cancer	0.00186	0.00539	CcSEcCtD
Methimazole—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00181	0.00524	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00173	0.00501	CcSEcCtD
Methimazole—Pruritus—Chlorambucil—ovarian cancer	0.00172	0.00497	CcSEcCtD
Methimazole—Urticaria—Topotecan—ovarian cancer	0.00171	0.00497	CcSEcCtD
Methimazole—Body temperature increased—Topotecan—ovarian cancer	0.00171	0.00494	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—ovarian cancer	0.00169	0.0049	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00168	0.00487	CcSEcCtD
Methimazole—Urticaria—Melphalan—ovarian cancer	0.00168	0.00486	CcSEcCtD
Methimazole—Paraesthesia—Vinorelbine—ovarian cancer	0.00166	0.0048	CcSEcCtD
Methimazole—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00162	0.00469	CcSEcCtD
Methimazole—Jaundice—Docetaxel—ovarian cancer	0.00161	0.00466	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00157	0.00454	CcSEcCtD
Methimazole—Alopecia—Paclitaxel—ovarian cancer	0.00154	0.00447	CcSEcCtD
Methimazole—Vomiting—Chlorambucil—ovarian cancer	0.00154	0.00446	CcSEcCtD
Methimazole—Agranulocytosis—Docetaxel—ovarian cancer	0.00154	0.00446	CcSEcCtD
Methimazole—Pruritus—Topotecan—ovarian cancer	0.00153	0.00442	CcSEcCtD
Methimazole—Pruritus—Melphalan—ovarian cancer	0.0015	0.00433	CcSEcCtD
Methimazole—Hepatitis—Docetaxel—ovarian cancer	0.00148	0.00429	CcSEcCtD
Methimazole—Urticaria—Vinorelbine—ovarian cancer	0.00147	0.00425	CcSEcCtD
Methimazole—Body temperature increased—Vinorelbine—ovarian cancer	0.00146	0.00423	CcSEcCtD
Methimazole—Nausea—Chlorambucil—ovarian cancer	0.00144	0.00417	CcSEcCtD
Methimazole—Vomiting—Topotecan—ovarian cancer	0.00137	0.00397	CcSEcCtD
Methimazole—Vertigo—Paclitaxel—ovarian cancer	0.00137	0.00396	CcSEcCtD
Methimazole—Leukopenia—Paclitaxel—ovarian cancer	0.00136	0.00394	CcSEcCtD
Methimazole—Rash—Topotecan—ovarian cancer	0.00136	0.00394	CcSEcCtD
Methimazole—Dermatitis—Topotecan—ovarian cancer	0.00136	0.00394	CcSEcCtD
Methimazole—Headache—Topotecan—ovarian cancer	0.00135	0.00392	CcSEcCtD
Methimazole—Vomiting—Melphalan—ovarian cancer	0.00134	0.00389	CcSEcCtD
Methimazole—Rash—Melphalan—ovarian cancer	0.00133	0.00386	CcSEcCtD
Methimazole—Dermatitis—Melphalan—ovarian cancer	0.00133	0.00386	CcSEcCtD
Methimazole—Alopecia—Docetaxel—ovarian cancer	0.00131	0.00379	CcSEcCtD
Methimazole—Pruritus—Vinorelbine—ovarian cancer	0.00131	0.00378	CcSEcCtD
Methimazole—Arthralgia—Paclitaxel—ovarian cancer	0.0013	0.00375	CcSEcCtD
Methimazole—Myalgia—Paclitaxel—ovarian cancer	0.0013	0.00375	CcSEcCtD
Methimazole—Nausea—Topotecan—ovarian cancer	0.00128	0.00371	CcSEcCtD
Methimazole—Nausea—Melphalan—ovarian cancer	0.00126	0.00364	CcSEcCtD
Methimazole—Oedema—Paclitaxel—ovarian cancer	0.00124	0.0036	CcSEcCtD
Methimazole—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00122	0.00352	CcSEcCtD
Methimazole—Vomiting—Vinorelbine—ovarian cancer	0.00117	0.0034	CcSEcCtD
Methimazole—Rash—Vinorelbine—ovarian cancer	0.00116	0.00337	CcSEcCtD
Methimazole—Dermatitis—Vinorelbine—ovarian cancer	0.00116	0.00337	CcSEcCtD
Methimazole—Headache—Vinorelbine—ovarian cancer	0.00116	0.00335	CcSEcCtD
Methimazole—Leukopenia—Docetaxel—ovarian cancer	0.00115	0.00334	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00113	0.00328	CcSEcCtD
Methimazole—Paraesthesia—Paclitaxel—ovarian cancer	0.00112	0.00323	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—ovarian cancer	0.00111	0.00322	CcSEcCtD
Methimazole—Somnolence—Paclitaxel—ovarian cancer	0.0011	0.0032	CcSEcCtD
Methimazole—Myalgia—Docetaxel—ovarian cancer	0.0011	0.00318	CcSEcCtD
Methimazole—Arthralgia—Docetaxel—ovarian cancer	0.0011	0.00318	CcSEcCtD
Methimazole—Nausea—Vinorelbine—ovarian cancer	0.0011	0.00318	CcSEcCtD
Methimazole—Dyspepsia—Paclitaxel—ovarian cancer	0.00109	0.00317	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00109	0.00316	CcSEcCtD
Methimazole—Jaundice—Epirubicin—ovarian cancer	0.00109	0.00314	CcSEcCtD
Methimazole—Oedema—Docetaxel—ovarian cancer	0.00105	0.00305	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—ovarian cancer	0.00104	0.00301	CcSEcCtD
Methimazole—Thrombocytopenia—Docetaxel—ovarian cancer	0.00103	0.00298	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—ovarian cancer	0.00103	0.00298	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00101	0.00292	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—ovarian cancer	0.001	0.00291	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—ovarian cancer	0.001	0.00289	CcSEcCtD
Methimazole—Urticaria—Paclitaxel—ovarian cancer	0.000987	0.00286	CcSEcCtD
Methimazole—Body temperature increased—Paclitaxel—ovarian cancer	0.000982	0.00284	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—ovarian cancer	0.000961	0.00278	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000959	0.00278	CcSEcCtD
Methimazole—Paraesthesia—Docetaxel—ovarian cancer	0.000945	0.00274	CcSEcCtD
Methimazole—Somnolence—Docetaxel—ovarian cancer	0.000936	0.00271	CcSEcCtD
Methimazole—Dyspepsia—Docetaxel—ovarian cancer	0.000927	0.00268	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—ovarian cancer	0.000925	0.00268	CcSEcCtD
Methimazole—Alopecia—Epirubicin—ovarian cancer	0.000883	0.00256	CcSEcCtD
Methimazole—Pruritus—Paclitaxel—ovarian cancer	0.000879	0.00254	CcSEcCtD
Methimazole—Body temperature increased—Docetaxel—ovarian cancer	0.000832	0.00241	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—ovarian cancer	0.000817	0.00237	CcSEcCtD
Methimazole—Vomiting—Paclitaxel—ovarian cancer	0.00079	0.00229	CcSEcCtD
Methimazole—Rash—Paclitaxel—ovarian cancer	0.000783	0.00227	CcSEcCtD
Methimazole—Dermatitis—Paclitaxel—ovarian cancer	0.000782	0.00227	CcSEcCtD
Methimazole—Vertigo—Epirubicin—ovarian cancer	0.000782	0.00226	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—ovarian cancer	0.000779	0.00226	CcSEcCtD
Methimazole—Headache—Paclitaxel—ovarian cancer	0.000778	0.00225	CcSEcCtD
Methimazole—Pruritus—Docetaxel—ovarian cancer	0.000745	0.00216	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—ovarian cancer	0.000741	0.00214	CcSEcCtD
Methimazole—Myalgia—Epirubicin—ovarian cancer	0.000741	0.00214	CcSEcCtD
Methimazole—Nausea—Paclitaxel—ovarian cancer	0.000738	0.00214	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—ovarian cancer	0.000723	0.00209	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—ovarian cancer	0.000721	0.00209	CcSEcCtD
Methimazole—Oedema—Epirubicin—ovarian cancer	0.00071	0.00206	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—ovarian cancer	0.000695	0.00201	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—ovarian cancer	0.000685	0.00198	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—ovarian cancer	0.000685	0.00198	CcSEcCtD
Methimazole—Vomiting—Docetaxel—ovarian cancer	0.000669	0.00194	CcSEcCtD
Methimazole—Rash—Docetaxel—ovarian cancer	0.000664	0.00192	CcSEcCtD
Methimazole—Dermatitis—Docetaxel—ovarian cancer	0.000663	0.00192	CcSEcCtD
Methimazole—Headache—Docetaxel—ovarian cancer	0.00066	0.00191	CcSEcCtD
Methimazole—Oedema—Doxorubicin—ovarian cancer	0.000657	0.0019	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000647	0.00187	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000643	0.00186	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—ovarian cancer	0.000638	0.00185	CcSEcCtD
Methimazole—Somnolence—Epirubicin—ovarian cancer	0.000631	0.00183	CcSEcCtD
Methimazole—Nausea—Docetaxel—ovarian cancer	0.000625	0.00181	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—ovarian cancer	0.000625	0.00181	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000599	0.00173	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—ovarian cancer	0.00059	0.00171	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—ovarian cancer	0.000584	0.00169	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—ovarian cancer	0.000578	0.00167	CcSEcCtD
Methimazole—Urticaria—Epirubicin—ovarian cancer	0.000564	0.00163	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—ovarian cancer	0.000561	0.00163	CcSEcCtD
Methimazole—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000535	0.00225	CbGpPWpGaD
Methimazole—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000522	0.0022	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.000522	0.0022	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000522	0.0022	CbGpPWpGaD
Methimazole—Urticaria—Doxorubicin—ovarian cancer	0.000522	0.00151	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—ovarian cancer	0.000519	0.0015	CcSEcCtD
Methimazole—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.000505	0.00212	CbGpPWpGaD
Methimazole—Pruritus—Epirubicin—ovarian cancer	0.000502	0.00145	CcSEcCtD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000499	0.0021	CbGpPWpGaD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000494	0.00208	CbGpPWpGaD
Methimazole—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000492	0.00207	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000489	0.00205	CbGpPWpGaD
Methimazole—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000488	0.00205	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.000471	0.00198	CbGpPWpGaD
Methimazole—Pruritus—Doxorubicin—ovarian cancer	0.000465	0.00135	CcSEcCtD
Methimazole—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.000455	0.00191	CbGpPWpGaD
Methimazole—Vomiting—Epirubicin—ovarian cancer	0.000451	0.00131	CcSEcCtD
Methimazole—Rash—Epirubicin—ovarian cancer	0.000448	0.0013	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—ovarian cancer	0.000447	0.0013	CcSEcCtD
Methimazole—Headache—Epirubicin—ovarian cancer	0.000445	0.00129	CcSEcCtD
Methimazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000444	0.00187	CbGpPWpGaD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000439	0.00185	CbGpPWpGaD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000423	0.00178	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000422	0.00178	CbGpPWpGaD
Methimazole—Nausea—Epirubicin—ovarian cancer	0.000422	0.00122	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—ovarian cancer	0.000418	0.00121	CcSEcCtD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000417	0.00175	CbGpPWpGaD
Methimazole—Rash—Doxorubicin—ovarian cancer	0.000414	0.0012	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—ovarian cancer	0.000414	0.0012	CcSEcCtD
Methimazole—Headache—Doxorubicin—ovarian cancer	0.000412	0.00119	CcSEcCtD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000404	0.0017	CbGpPWpGaD
Methimazole—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000403	0.0017	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000401	0.00168	CbGpPWpGaD
Methimazole—Nausea—Doxorubicin—ovarian cancer	0.00039	0.00113	CcSEcCtD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000385	0.00162	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	0.000383	0.00161	CbGpPWpGaD
Methimazole—TPO—Metabolism—YAP1—ovarian cancer	0.000363	0.00153	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000342	0.00144	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000328	0.00138	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000326	0.00137	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000322	0.00135	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	0.000309	0.0013	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000305	0.00128	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.000303	0.00127	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000298	0.00125	CbGpPWpGaD
Methimazole—TPO—Metabolism—FASN—ovarian cancer	0.000296	0.00125	CbGpPWpGaD
Methimazole—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000293	0.00123	CbGpPWpGaD
Methimazole—TPO—Metabolism—SLC5A5—ovarian cancer	0.000291	0.00123	CbGpPWpGaD
Methimazole—TPO—Metabolism—SLC2A1—ovarian cancer	0.000281	0.00118	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP1B1—ovarian cancer	0.00027	0.00113	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000264	0.00111	CbGpPWpGaD
Methimazole—TPO—Metabolism—PPP2R1A—ovarian cancer	0.000239	0.00101	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NME2—ovarian cancer	0.000233	0.000981	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000233	0.000981	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00023	0.000968	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000223	0.000938	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000223	0.000938	CbGpPWpGaD
Methimazole—TPO—Metabolism—ABCB1—ovarian cancer	0.000222	0.000934	CbGpPWpGaD
Methimazole—TPO—Metabolism—TYMS—ovarian cancer	0.000218	0.000918	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000218	0.000918	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000215	0.000903	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000213	0.000895	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000212	0.00089	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00021	0.000883	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NME2—ovarian cancer	0.000188	0.000792	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000185	0.00078	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NME2—ovarian cancer	0.000184	0.000776	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000183	0.00077	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000182	0.000765	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00018	0.000757	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000179	0.000754	CbGpPWpGaD
Methimazole—TPO—Metabolism—CAV1—ovarian cancer	0.000176	0.00074	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000171	0.000717	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000167	0.000702	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000167	0.000702	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000167	0.000702	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000164	0.00069	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CG—ovarian cancer	0.00016	0.000674	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000158	0.000663	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYTB—ovarian cancer	0.00015	0.000632	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NME2—ovarian cancer	0.000142	0.000598	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CD—ovarian cancer	0.000141	0.000592	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.00014	0.00059	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00014	0.00059	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000138	0.000582	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000134	0.000563	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PPP1CC—ovarian cancer	0.000131	0.000553	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—BRIP1—ovarian cancer	0.000131	0.000553	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NME2—ovarian cancer	0.000131	0.00055	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NME2—ovarian cancer	0.00013	0.000546	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CB—ovarian cancer	0.000123	0.000516	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYTB—ovarian cancer	0.000121	0.00051	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000121	0.000508	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYTB—ovarian cancer	0.000119	0.0005	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NME2—ovarian cancer	0.000111	0.000466	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00011	0.000463	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPP1CC—ovarian cancer	0.000106	0.000446	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BRIP1—ovarian cancer	0.000106	0.000446	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTEN—ovarian cancer	0.000106	0.000446	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPP1CC—ovarian cancer	0.000104	0.000437	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BRIP1—ovarian cancer	0.000104	0.000437	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.84e-05	0.000414	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.41e-05	0.000396	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYTB—ovarian cancer	9.17e-05	0.000386	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.97e-05	0.000377	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.96e-05	0.000377	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—YAP1—ovarian cancer	8.82e-05	0.000371	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NME2—ovarian cancer	8.56e-05	0.00036	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYTB—ovarian cancer	8.43e-05	0.000355	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYTB—ovarian cancer	8.36e-05	0.000352	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.17e-05	0.000344	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPP1CC—ovarian cancer	8.02e-05	0.000337	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—BRIP1—ovarian cancer	8.02e-05	0.000337	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.67e-05	0.000322	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CA—ovarian cancer	7.48e-05	0.000315	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPP1CC—ovarian cancer	7.37e-05	0.00031	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BRIP1—ovarian cancer	7.37e-05	0.00031	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BRIP1—ovarian cancer	7.31e-05	0.000307	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPP1CC—ovarian cancer	7.31e-05	0.000307	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—FASN—ovarian cancer	7.19e-05	0.000302	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYTB—ovarian cancer	7.15e-05	0.0003	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—YAP1—ovarian cancer	7.11e-05	0.000299	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SLC5A5—ovarian cancer	7.07e-05	0.000297	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.98e-05	0.000294	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—YAP1—ovarian cancer	6.97e-05	0.000293	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SLC2A1—ovarian cancer	6.83e-05	0.000287	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP1B1—ovarian cancer	6.55e-05	0.000275	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPP1CC—ovarian cancer	6.25e-05	0.000263	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BRIP1—ovarian cancer	6.25e-05	0.000263	CbGpPWpGaD
Methimazole—TPO—Metabolism—AKT1—ovarian cancer	6.11e-05	0.000257	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.84e-05	0.000246	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	5.81e-05	0.000244	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—FASN—ovarian cancer	5.8e-05	0.000244	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SLC5A5—ovarian cancer	5.7e-05	0.00024	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—FASN—ovarian cancer	5.68e-05	0.000239	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC5A5—ovarian cancer	5.59e-05	0.000235	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYTB—ovarian cancer	5.51e-05	0.000232	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SLC2A1—ovarian cancer	5.51e-05	0.000232	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC2A1—ovarian cancer	5.4e-05	0.000227	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ABCB1—ovarian cancer	5.39e-05	0.000227	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—YAP1—ovarian cancer	5.38e-05	0.000226	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.33e-05	0.000224	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.32e-05	0.000224	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—TYMS—ovarian cancer	5.29e-05	0.000223	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1B1—ovarian cancer	5.28e-05	0.000222	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1B1—ovarian cancer	5.17e-05	0.000218	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—YAP1—ovarian cancer	4.94e-05	0.000208	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—YAP1—ovarian cancer	4.9e-05	0.000206	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.85e-05	0.000204	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.82e-05	0.000203	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.82e-05	0.000203	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	4.68e-05	0.000197	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.68e-05	0.000197	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	4.59e-05	0.000193	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.55e-05	0.000191	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—FASN—ovarian cancer	4.38e-05	0.000184	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ABCB1—ovarian cancer	4.35e-05	0.000183	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.31e-05	0.000181	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—TYMS—ovarian cancer	4.27e-05	0.00018	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CAV1—ovarian cancer	4.27e-05	0.000179	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.26e-05	0.000179	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ABCB1—ovarian cancer	4.26e-05	0.000179	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—YAP1—ovarian cancer	4.19e-05	0.000176	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—TYMS—ovarian cancer	4.18e-05	0.000176	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.16e-05	0.000175	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.15e-05	0.000174	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.08e-05	0.000171	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—FASN—ovarian cancer	4.03e-05	0.000169	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—FASN—ovarian cancer	4e-05	0.000168	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.99e-05	0.000168	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC5A5—ovarian cancer	3.97e-05	0.000167	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC5A5—ovarian cancer	3.93e-05	0.000165	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—ovarian cancer	3.89e-05	0.000163	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC2A1—ovarian cancer	3.83e-05	0.000161	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC2A1—ovarian cancer	3.8e-05	0.00016	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.72e-05	0.000156	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1B1—ovarian cancer	3.67e-05	0.000154	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.64e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.64e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.54e-05	0.000149	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.52e-05	0.000148	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CAV1—ovarian cancer	3.44e-05	0.000145	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CD—ovarian cancer	3.42e-05	0.000144	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—FASN—ovarian cancer	3.41e-05	0.000144	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAV1—ovarian cancer	3.37e-05	0.000142	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.36e-05	0.000141	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.29e-05	0.000138	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.26e-05	0.000137	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.24e-05	0.000136	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—YAP1—ovarian cancer	3.23e-05	0.000136	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—TYMS—ovarian cancer	3.23e-05	0.000136	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.23e-05	0.000136	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.21e-05	0.000135	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.18e-05	0.000134	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.14e-05	0.000132	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.11e-05	0.000131	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.07e-05	0.000129	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.02e-05	0.000127	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—ovarian cancer	3e-05	0.000126	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.98e-05	0.000125	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TYMS—ovarian cancer	2.97e-05	0.000125	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TYMS—ovarian cancer	2.94e-05	0.000124	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.76e-05	0.000116	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CD—ovarian cancer	2.76e-05	0.000116	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.74e-05	0.000115	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.7e-05	0.000114	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—FASN—ovarian cancer	2.64e-05	0.000111	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAV1—ovarian cancer	2.6e-05	0.000109	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.59e-05	0.000109	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—ovarian cancer	2.57e-05	0.000108	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.56e-05	0.000108	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TYMS—ovarian cancer	2.52e-05	0.000106	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.5e-05	0.000105	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.49e-05	0.000105	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.4e-05	0.000101	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.4e-05	0.000101	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAV1—ovarian cancer	2.39e-05	0.000101	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAV1—ovarian cancer	2.37e-05	9.97e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.37e-05	9.96e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.35e-05	9.9e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.27e-05	9.53e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.18e-05	9.16e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.16e-05	9.08e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.13e-05	8.95e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.08e-05	8.76e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—ovarian cancer	2.08e-05	8.73e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—ovarian cancer	2.03e-05	8.55e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAV1—ovarian cancer	2.03e-05	8.52e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.98e-05	8.31e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TYMS—ovarian cancer	1.94e-05	8.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.94e-05	8.14e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.92e-05	8.06e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.9e-05	7.99e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.85e-05	7.76e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.82e-05	7.63e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.82e-05	7.63e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.67e-05	7.02e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.66e-05	6.96e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.62e-05	6.82e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—ovarian cancer	1.57e-05	6.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAV1—ovarian cancer	1.56e-05	6.58e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—ovarian cancer	1.48e-05	6.24e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.46e-05	6.16e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—ovarian cancer	1.44e-05	6.07e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.43e-05	6.03e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—ovarian cancer	1.43e-05	6.02e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.42e-05	5.99e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.41e-05	5.95e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.25e-05	5.27e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—ovarian cancer	1.22e-05	5.14e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—ovarian cancer	1.2e-05	5.03e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—ovarian cancer	1.17e-05	4.93e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.11e-05	4.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.09e-05	4.59e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.02e-05	4.28e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.01e-05	4.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—ovarian cancer	9.43e-06	3.97e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—ovarian cancer	9.04e-06	3.8e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—ovarian cancer	8.62e-06	3.63e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—ovarian cancer	8.32e-06	3.5e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—ovarian cancer	8.24e-06	3.47e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—ovarian cancer	7.05e-06	2.96e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	6.66e-06	2.8e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—ovarian cancer	5.44e-06	2.29e-05	CbGpPWpGaD
